General Information of Drug (ID: DMIRGTZ)

Drug Name
ACHM-CNGA3 Drug Info
Indication
Disease Entry ICD 11 Status REF
Achromatopsia 9B70 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMIRGTZ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AAV-CNGA3 DMNZJAE Achromatopsia 9B70 Phase 1/2 [2]
L-(cis)-diltiazem DMK07MI Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cyclic nucleotide-gated channel alpha-3 (CNGA3) TTW0QOV CNGA3_HUMAN Not Available [1]

References

1 Clinical pipeline report, company report or official report of Applied Genetic Technologies.
2 Clinical pipeline report, company report or official report of MeiraGTx.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 396).